Baumer SA
Baumer SA is a medical equipment and supplies company that generates revenue through the distribution and sale of healthcare products and services.
Business. Baumer SA (BALM4.SA) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Baumer SA is headquartered in Brazil and is listed on the B3 (São Paulo) stock exchange. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Baumer SA (BALM4.SA) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Baumer SA is headquartered in Brazil and is listed on the B3 (São Paulo) stock exchange. Specific details regarding operating segments and geographic revenue mix are not available.
Baumer SA maintains a conservative capital structure with a debt-to-equity ratio of 0.13, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 2.86, suggesting it can cover short-term obligations but with limited excess capacity. However, the company's free cash flow is negative at -506,000 BRL, and its net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, Baumer SA's return on equity (ROE) is 2.7%, and its return on assets (ROA) is 1.58%. These figures are below the typical thresholds for high-performing healthcare equipment firms, indicating that the company is not generating strong returns relative to its equity and asset base. The operating margin, calculated as operating income of 4,264,000 BRL on revenue of 36,320,000 BRL, is 11.74%, which is in line with the industry's median but not exceptional.
The company's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess geographic or segment concentration risk. However, the lack of segmentation data suggests that the company may have a relatively undiversified revenue base, which could expose it to regional or product-specific risks.
Looking ahead, the company's growth trajectory is not clearly defined in the available data. The absence of specific revenue growth projections or historical growth rates makes it difficult to assess the company's future performance. The capital expenditure of -2,649,000 BRL indicates that the company is investing in its operations, but the negative free cash flow suggests that these investments are not yet generating positive cash returns.
The risk assessment for Baumer SA highlights a medium liquidity risk and a low dilution risk. The company's shares outstanding are the same for both basic and diluted shares, indicating no imminent threat of share dilution. However, the negative free cash flow and the negative net cash position after debt suggest that the company may need to raise additional capital in the near term, which could introduce new risks.
There are no recent events or filings mentioned in the available data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests that the company may not be actively communicating with investors or disclosing material developments.
- Baumer SA has a conservative capital structure with a low debt-to-equity ratio of 0.13.
- The company's return on equity (2.7%) and return on assets (1.58%) are below typical thresholds for high-performing healthcare equipment firms.
- The company's liquidity position is characterized as medium risk, with a current ratio of 2.86.
- The company's free cash flow is negative at -506,000 BRL, and its net cash position is negative after subtracting total debt.
- The company's growth trajectory is not clearly defined in the available data.
- The company has a low dilution risk, with no imminent threat of share dilution.
Bull / Bear case
Generated · model-assistedBaumer generated BRL 213.7 million in FY0 revenue, reflecting a strong 12.4% four-year compound annual growth rate.
Baumer's 11.7% operating margin vastly outperforms the 3.1% cohort median, demonstrating superior operational efficiency.
With a debt-to-equity ratio of 0.13, Baumer maintains a conservative leverage profile below the 0.20 cohort median.
The firm exhibits low dilution and credit risk flags, suggesting a stable capital structure and limited downside threats.
Return on equity stands at a low 2.7%, indicating inefficient use of shareholder capital despite high margins.
Operating income fell 3.6% year-over-year to BRL 34.7 million, showing stagnation in core operational earnings.
The company faces medium liquidity risk, which could constrain its ability to manage short-term financial obligations.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Baumer SA Market data — financials · 2026-05-27